Among the KEGG pathways, EGFR tyrosine kinase inhibitor resistance, ErbB signaling pathway, MAPK signaling pathway and calcium signaling pathway were involved in ChRCC tumorigenesis (Supplementary file Figure 9). The gene discussed is EGFR; the disease is chromophobe renal cell carcinoma.